Compare Heron Therapeutics Inc (HRTX) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Jabil Inc — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Jabil Inc trades at $318.52 (market cap $32.06B). The key difference: Jabil Inc is far larger — about 350.5× Heron Therapeutics Inc's market cap, and Jabil Inc pays a 0.1% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | JBL | |
|---|---|---|
Market Cap | $91.46M | $32.06B |
Sector | Health | Technology |
52-Week High | $1.96 | $385.50 |
52-Week Low | $0.39 | $192.49 |
Enterprise Value | $189.36M | $34.59B |
Dividend Yield | — | 0.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
